Why Didn't Tilray Brands Make a Bid for Aurora Cannabis?
Aurora Cannabis Record International Medical Revenue – Downloadable Quarterly Update Report
Aurora Cannabis Inc. (ACB) Q2 Earnings and Revenues Top Estimates
Aurora Cannabis Announces Fiscal 2027 Second Quarter Results
Aurora Cannabis Q2 EPS $(0.32) Misses $(0.09) Estimate, Sales $86.021M Beat $72.167M Estimate
The Battle for the Biggest Weed Merger Ends in Canada
Organigram to Acquire Aurora and Establish a Global Cannabis Leader
Organigram outbids Curaleaf with C$561M deal for Aurora Cannabis
Organigram Global to Acquire Aurora Cannabis for CA$7.80 per Common Share
Organigram Swoops In To Acquire Aurora Cannabis, Topping Curaleaf’s Rival Bid – ACB Stock Surges To Over 10-Month Highs
Canadian Investment Regulatory Organization Trade Resumption - ACB
Canadian Investment Regulatory Organization Trading Halt - ACB
Aurora Cannabis Stock Surges on Organigram Deal
Organigram To Acquire Aurora Cannabis For C$561 Million, Or C$7.80 Per Share
Aurora Cannabis to Host Second Quarter 2027 Investor Conference Call
ACB's Q2 Earnings on Deck: International Medical Cannabis in Focus
Aurora Cannabis Announces the Alberta Securities Commission has dismissed Curaleaf's Application and ruled in favour of the Company's At-the-Market Program
Alberta Securities Commission Dismisses Curaleaf Holdings's Application To Halt Aurora Cannabis' February At-The-Market Program
Should You Buy Curaleaf Stock Amid Its Hostile Bid for Aurora?
Aurora Rejects Curaleaf's Higher Bid, But the Takeover Fight Isn't Over
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.